Skip to main content
Fig. 9 | BMC Complementary Medicine and Therapies

Fig. 9

From: Identifying potential therapeutic targets of mulberry leaf extract for the treatment of type 2 diabetes: a TMT-based quantitative proteomic analysis

Fig. 9

Components—Targets Molecular Docking. The molecular docking poses of Kuwanon C—ApoA1 (A), Luteolin—ApoA1 (B), Kaempferol—ApoA1 (C), Formononetin—ApoA1 (D), 2-Hydroxycinnamic acid—ApoA1 (E), Quercetin—ApoA1 (F), Esculetin—ApoA4 (G), 7-Hydroxycoumarine—ApoA4 (H), Formononetin—ApoA4 (I), Luteolin—ApoA4 (J), Scopoletin—ApoA4 (K), Quercetin—ApoA4 (L)

Back to article page